baber/WOPTO huggingface dataset:
Patent CA-2525286-A1 (CA)
Inventor: BEHAN DOMINIC
IPC: G01N33/68
Filed: 2004-05-18
Abstract: The invention provides materials and methods relating to G-protein coupled receptor (GPCR) oligomers. Complexes of two or more GPCRs associated with G-proteins are provided. Also provided are fusion proteins comprising a GPCR and a G-protein, nucleic acids, expression vectors and host cells. Methods of producing the complexes and fusion proteins of the invention are also provided.
Patent CA-2525519-A1 (CA)
Title: Generation and isolation of antigen-specific t cells
Inventor: BONYHADI MARK
IPC: A61K39/00
Filed: 2003-12-19
Abstract: The present invention relates generally to methods for generating, expanding , and isolating antigen-specific T cells. Compositions of antigen-specific T cells activated and expanded by the methods herein are further provided.</SD OAB>
Patent CA-2526185-A1 (CA)
Title: Electrolyte composition and photoelectric conversion element using same
Inventor: MATSUI HIROSHI
IPC: H01G9/20
Filed: 2004-05-27
Abstract: Disclosed is an electrolyte composition containing a polymer compound which has a cation structure in the main chain or side chain of the polymer which cation structure is selected from the group consisting of ammonium, phosphonium and sulfonium and a halide ion and/or a polyhalide as a counter-anion. The electrolyte composition is in a solid state.
Patent CA-2527729-A1 (CA)
Title: Bath aeration
Inventor: STRICKLAND TIMOTHY VAUGHAN
IPC: A61H33/02
Filed: 2004-05-28
Abstract: An aerated bath is disclosed which allows an effervescent effect to be provided. A liquid flow (56) including a significant volume of entrained air bubbles (10) is ejected into the bath such that the flow follows the base (54) of the bath under the influence of the Coanda effect. Once the transport velocity of the liquid flow is too low for continued entrainment of the bubbles they rise to the surface to provide the effervescent effect.
Patent CA-2533792-A1 (CA)
Title: Medicaments for inhalation comprising steroids and fluorene carboxylic acid esters
Inventor: PIEPER MICHAEL P
IPC: A61K31/56
Filed: 2004-07-17
Abstract: The present invention relates to novel pharmaceutical compositions based on steroids and salts of a new anticholinergic, processes for preparing them and their use in the treatment of respiratory complaints.
Patent CA-2536660-A1 (CA)
Inventor: HONDO MINORU
IPC: H05B3/30
Filed: 2003-10-31
Abstract: L'invention concerne un organe de chauffage à fusion d'huile solide du type à plaques, comprenant : un élément de chauffe, un corps métallique du type plaque recouvrant intégralement la partie intermédiaire de l'élément de chauffe, de sorte que la chaleur soit conduite entre eux, un corps de gainage externe reliant les deux parties terminales de l'élément de chauffe, une poignée prévue sur le corps de gainage extérieur et un corps de connexion de l'alimentation électrique par lequel l'énergie électrique est fournie à l'élément de chauffe.
Patent CA-2540109-A1 (CA)
Title: Method for stabilization of diarylvinylene compounds
Inventor: AIMOTO MASAHARU
IPC: A61P25/24
Filed: 2004-09-29
Abstract: (see formula I) (wherein Y1 and Y2 may be the same or different and each represents a hydrogen atom, halogen or lower alkyl; and Z and A may be the same or different and each represents substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl) The present invention provides, for example, a method for stabilization of a diarylvinylene compound such as a compound represented by the above formula (I) or the like, or a pharmaceutically acceptable salt thereof in a solid formulation containing the diarylvinylene compound or the pharmaceutically acceptable salt thereof, which comprises allowing an inorganic substance and/or a colorant to exist in the solid formulation, and the like.
Patent CA-2540444-A1 (CA)
Inventor: HALL BRENT S
IPC: H04H60/31
Filed: 2006-03-20
Abstract: A preferred method for transmitting digital information through a fluid medium includes generating a first and a second pressure pulse in the fluid medium, and encoding the digital information in the second pressure pulse by generating the second pressure pulse a predetermined amount of time after generating the first pressure pulse. The preferred method also includes sensing the first and the second pressure pulses, and decoding the digital information by determining the elapsed time between the first pressure pulse and the second pressure pulse.
Patent CA-2540578-A1 (CA)
Title: An intramedullary implant for fracture fixation
Inventor: MEDOFF ROBERT J
IPC: A61B17/80
Filed: 2004-06-25
Abstract: An implant for fracture fixation having external portion shaped to be externally engaged on and secured to a stable bone fragment on one side of a bone fracture and an integral internal portion sized and shaped for being inserted into and accommodated in an intramedullary canal of an unstable bone fragment on an opposite side of the fracture. The internal portion has an end with a rounded tip of bullet-shape for fitting in an apical space at an endosteal surface of the unstable bone fragment to provide a bearing support for the unstable bone fragment over a large area.
Patent CA-2542860-A1 (CA)
Inventor: MIYAWAKI ATSUSHI
IPC: C12N5/10
Filed: 2004-10-15
Abstract: A novel fluorescence indicator for analyzing an intermolecular interaction or intramolecular structural change with the use of fluorescence resonance energy transfer (FRET). There is provided a fluorescence indicator having such a structure that a donor fluorescent protein and an acceptor fluorescent protein are linked to both ends of a target sequence for analyte wherein the three-dimensional structure of the indicator is changed by analyte liking to the target sequence or action on the target sequence to thereby induce fluorescence resonance energy transfer (FRET), characterized in that the donor fluorescent protein and/or acceptor fluorescent protein is a circular permutation variant fluorescent protein obtained by interchanging between N-terminus side amino acid sequence and C-terminus side amino acid sequence of wild type fluorescent protein or its variant protein and is a fluorescent protein having substantially the same fluorescence peak wavelength as that of the fluorescent protein before being subjected to the circular permutation variation.
Patent CA-2544305-A1 (CA)
Title: Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for nmr-structural analysis of proteins
Inventor: KAINOSHO MASATSUNE
IPC: C07C229/36
Filed: 2004-11-01
Abstract: A phenylalanine labeled with a stable isotope, wherein a carbon atom bonded to an amino acid residue in a phenyl group is 13C, two to four carbon atoms of the residual five carbon atoms constituting said phenyl group are 12C atoms, to which deuterium atoms are bonded, and the further residual carbon atoms are 13C atoms, to which hydrogen atoms are bonded; a tyrosine labeled with a stable isotope, wherein a carbon atom bonded to an amino acid residue in a phenyl group is 13C, a carbon atom bonded to a hydroxyl group (an OH group) in a phenyl group is 12C or 13C, two to four carbon atoms of the residual four carbon atoms constituting said phenyl group are 12C atoms, to which deuterium atoms are bonded, and the further residual carbon atoms are 13C atoms, to which hydrogen atoms are bonded; or the like. The above amino acid labeled with a stable isotope allows the resolution of the complexity of aromatic ring NMR signals, which is the greatest reason for difficulties of NMR analysis in the case of a uniformly labeled amino acid residue having been used conventionally, and thus can markedly improve the sensitivity of the analysis.
Patent CA-2545378-A1 (CA)
Title: Electric lamp having an outer bulb
Inventor: GRAEF JUERGEN
IPC: H01J61/30
Filed: 2006-04-28
Abstract: The elongate bulb (1) of the lamp, which defines a longitudinal axis (A), is sealed at mutually opposing ends by sealing parts (6; 32), to which an outer bulb is fixed, the ratio between the total length of the outer bulb LAKO and the inner length of the inner volume LEG being between 1.3 and 4, preferably 1.5 and 3.
Patent CA-2547346-A1 (CA)
Inventor: DECKWER ROLAND
IPC: A01N25/02
Filed: 2004-11-19
Abstract: The invention relates to a concentrated oily suspension containing one or several types of herbicide agents of a thienyl-sulphonamide group and one or several types of organic solvents. The inventive concentrated oily suspensio n is particularly suitable for plant protection.
Patent CA-2547400-A1 (CA)
Title: Circuitry for optimization of power consumption in a system employing multiple electronic components, one of which is always powered on
Inventor: CRIVELLI ROCCO
IPC: H02J3/02
Filed: 2006-05-19
Abstract: Circuitry for conserving power in a system employing multiple electronic components of which a first electronic component operates at a first frequency and is continuously powered on by a power source. The system further includes a second electronic component operating at a second frequency different than that of the first frequency of the first electric component, the second electronic component being maintained in a powered off state in which no energy whatsoever is consumed by the second electronic component until energized in response to a power enabling signal generated by the first electronic component based on demand of the particular function to be performed by the second electronic component. The first and second electronic components may be processors, wherein the frequency of the first processor is lower than that of the second processor.
Patent CA-2549431-A1 (CA)
Inventor: MARUOKA KEIJI
IPC: C07C229/36
Filed: 2005-01-27
Abstract: A compound of the following formula (I). This compound (I) can be produced b y reacting a 1,1'-binaphthyl 2,2'-dimethylenebromide derivative which can be produced through a relatively small number of steps with an easily available secondary amine. The compound (I) is useful as a chiral phase-transfer catalyst.
Patent CA-2549987-A1 (CA)
Inventor: NATHANSON JEREMY J
IPC: A61F13/00
Filed: 2005-01-03
Abstract: A strap tension indicator for orthopedic brace is provided. Certain embodiments include a strap tab cap that is slidable relative to a rigid brace frame member (34) .As tension in the strap (33, 102, 106) increases or decreases, the strap tab cap slides with respect to the frame member, covering and uncovering various indicator portions on the frame member. Certain other embodiments include a strap tab (130) that is slidable relative to a strap tab cap. As tension in the strap increases or decreases, the strap tab slides relative to the strap tab cap, covering and uncovering various indicator portions on the strap tab and/or the frame member. The strap tension indicator provides positive indication of optimal strap tension. Certain embodiments also provide positive indication of inadequate or excessive strap tension.
Patent CA-2556812-A1 (CA)
Title: Air/fuel conditioning
Inventor: COLLINS PAUL ANTHONY
IPC: F02M31/14
Filed: 2005-02-24
Abstract: Apparatus, and method, for conditioning air and fuel supplied to a combustor comprising means (5) for electrostatically charging air supplied to a combustor at a first polarity, means (12) for electrostatically charging fuel supplied to such combustor at opposite polarity to said first polarity, and means (15, 19; 20) for preheating such fuel.
Patent CA-2558787-A1 (CA)
Inventor: WOLF MARIE-CHRISTINE
IPC: A61K9/22
Filed: 2005-03-21
Abstract: The invention relates to pharmaceutical compositions comprising 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide (also referred to as "licarbazepine") as drug substance.
Patent CA-2561843-A1 (CA)
Inventor: GRANDI SIMONE
IPC: B01F25/60
Filed: 2004-09-01
Abstract: Cette invention concerne un homogénéisateur (1) pour traitement continu de fluides sous très haute pression, comprenant au moins un piston animé d'un mouvement alternatif (5) dans une chambre de compression (6) et une chambre de guidage (11) entre une position d'admission de fluide et une position de refoulement. Ladite chambre de compression (6) ouvre sur un collecteur (27) à l'intérieur d'un bloc (26) d'où partent un tube de refoulement (32) et un tube d'admission (31). Un premier ensemble de joint (21) est logée dans la chambre de guidage (11), un second ensemble de joint (24) se trouve près de l'intersection entre la chambre de compression (6) et la chambre de guidage (11), et une troisième ensemble de joint (35) est disposé en amont et en aval de chacune des vannes (28, 29) et l'intersection du collecteur (27) et de la chambre de compression (6).
Patent CA-2562506-A1 (CA)
Inventor: SCHREIBER JEFFREY B
IPC: G01S1/00
Filed: 2005-04-12
Abstract: In one embodiment, a method for DMR includes generating first tracking reports of first data units received at one or more receptors from one or more remote units, generating second tracking reports of first data units received at one of one or more centrals, and generating delivery reports of second data units extracted at the central from the first data units received at the central.  The method includes, using the delivery reports, identifying missing second data units that should have been received at the central, but were not. The method includes, using one or more of the tracking reports, mapping the missing second data units to one or more first data units and determining a best source for retransmission of the first data units mapped to the missing second data units. The method includes generating a retransmit request for the first data units mapped to the missing second data units and communicating the retransmit request to the best source.
Patent CA-2562854-A1 (CA)
Title: Incandescent filament for an incandescent lamp and incandescent lamp
Inventor: GLOECKLER FRANK
IPC: H01K1/32
Filed: 2005-05-02
Abstract: The invention relates to a spiral-wound filament (110) for an incandescent lamp, comprising two lead-in wires (1102, 1103), said lead-in wires (1102, 1103) having one bent limb (11021, 11031) each which are arranged in a joint plane that extends off-set in parallel to the winding axis (1104) of the spiral-wound filament (110). The invention also relates to an incandescent lamp that has an axially symmetric lamp base (100) and a spiral-wound filament (110) that is off-set in parallel to the lamp base axis (A-A).
Patent CA-2565359-A1 (CA)
Inventor: HODSDON JERRY G
IPC: G06F3/12
Filed: 2005-04-29
Abstract: Printing stock for use in making a sign that includes a face sheet and a backing sheet. The sign is formed, for example, by overlapping a plurality of sheets of the printing stock, with the sheets arranged in a pattern to form a desired image of the sign. In a number of embodiments, the sheets of printing stock may be received through and printed on by a small~office, home-office (SOHO) printer. In other embodiments, the sheets of printing stock are of standard size for use with SOHO printers, i.e., A4, (21.6x27.9cms ) and legal size. The face sheet includes a printing surface for receiving ink and an adhesive surface for receiving the backing sheet. The face includes a face cut forming a margin and a face sub-sheet such that at least a portion of the margin is separable from the face sub-sheet. The backing sheet may include a backing cut forming a border and a backing sub-sheet such that at least a portion of the border is separable from the backing sub-sheet so that at least a portion of the adhesive surface of the face sheet is exposable. The face may include a plurality of registration marks for enabling the face sub-sheet from one sheet of printing stock that is separated from at least a portion of the margin thereof to be positioned with respect to the face sub-sheet from another sheet of printing stock.
Patent CA-2566418-A1 (CA)
Inventor: UBALIJORO ELIANE
IPC: C12P19/34
Filed: 2005-05-10
Abstract: Polynucleotide primers and probes for the specific amplification and detection of S. aureus in samples are provided. The polynucleotide primers and probes are targeted to the S. aureus gene and are capable of detecting a wide range of S. aureus strains. The primers and probes can be used in real time diagnostic assays for rapid detection of S. aureus in a variety of situations.  Kits comprising the primers and probes are also provided.
Patent CA-2566579-A1 (CA)
Title: Method and apparatus for vaporizing a sterilant fluid using microwave energy
Inventor: VOYTEN STANLEY M
IPC: A61L2/24
Filed: 2005-03-10
Abstract: A method and apparatus (10) for vaporizing a sterilant fluid using microwave energy (90). A sterilant fluid is atomized to produce a spray, mist or fog of sterilant fluid. The atomized sterilant fluid is then exposed to microwave energy produced by a microwave generator (90). Molecules of at least one chemical component of the sterilant fluid rotate in response to exposure to the microwave energy, thereby vaporizing (20) the sterilant fluid (100).
Patent CA-2566658-A1 (CA)
Title: Embedded electrode conformations for balanced energy, power, and cost in an alkaline cell
Inventor: GORDON JOHN
IPC: H01M50/107
Filed: 2004-10-22
Abstract: A battery cell, such as a cylindrical or prismatic alkaline cell, is disclosed having significantly improved capacity utilization at mid-range power levels of discharge by implementing a curvilinear-like inner electrode configuration that provides moderated surface area between the inner and outer electrodes as compared to high-power discharge applications utilizing a densely corrugated geometry for the inner electrode.
Patent CA-2572959-A1 (CA)
Inventor: HENNING JASON PATRICK
IPC: H01L21/28
Filed: 2005-06-30
Abstract: A method of producing an ohmic contact and a resulting ohmic contact structure are disclosed. The method includes the steps of forming a deposited film of nickel and silicon on a silicon carbide surface at a temperature below which either element will react with silicon carbide and in respective proportions so that the atomic fraction of silicon in the deposited film is greater than the atomic fraction of nickel, and heating the deposited film of nickel and silicon to a temperature at which nickel-silicon compounds will form with an atomic fraction of silicon greater than the atomic fraction of nickel but below the temperature at which either element will react with silicon carbide.  The method can further include the step of annealing the nickel-silicon compound to a temperature higher than the heating temperature for the deposited film, and within a region of the phase diagram at which free carbon does not exist.
Patent CA-2574434-A1 (CA)
Title: Power supply monitoring for an implantable device
Inventor: GUZMAN ALBERT W
IPC: A61N1/378
Filed: 2005-07-27
Abstract: A method and an apparatus for projecting an end of service (EOS) and/or an elective replacement indication (ERI) of a component in an implantable device and for determining an impedance experienced by a lead associated with the implantable device. An active charge depletion of an implantable device is determined. An inactive charge depletion of the implantable device is determined. A time period until an end of service (EOS) and/or elective replacement indication (ERI) of a power supply associated with the IMD based upon the active charge depletion, the inactive charge depletion, and the initial and final (EOS) battery charges, is determined. Furthermore, to determine the impedance described above, a substantially constant current signal is provided through a first terminal and a second terminal of the lead.  A voltage across the first and second terminals is measured. An impedance across the first and second terminals is determined based upon the constant current signal and the measured voltage.
Patent CA-2574500-A1 (CA)
Title: D-pyranosyl-substituted phenyls, medicaments containing said compounds, use thereof, and method for the production thereof
Inventor: BARSOUMIAN EDWARD LEON
IPC: C07D309/10
Filed: 2005-09-28
Abstract: D-pyranosyl-substituted phenyls of general formula I wherein the groups R<SUP>1 </SUP>to R<SUP>5</SUP>, X, Z and R<SUP>7a</SUP>, R<SUP>7b</SUP>, R<SUP>7c </SUP>are defined as in claim 1, have an inhibiting effect on the sodium-dependent glucose cotransporter SGLT. The present invention also relates to pharmaceutical compositions for the treatment of metabolic disorders.
Patent CA-2574617-A1 (CA)
Inventor: HARRISON DALE
IPC: B65D88/34
Filed: 2005-07-22
Abstract: Disclosed is a solid/liquid reaction process comprising the steps of: a) forming a slurry of a solid and a solution containing a species (SA) reactive with the solid and convertible to a species in the gas phase (SG); b) conducting a reaction between the solid and the species SA in a slurry in a vessel (1, 2, 3); and c) controlling a process condition of the slurry to minimise reactive conversion of species SA to species SG. Reactive conversion of species SA to species SG in the vessel (1, 2, 3) is minimised by the placement of laminar slurry cover (20) buoyant with respect to the slurry in the vessel (1, 2, 3). A process of particular importance is the process of cyanidation of gold ores in which reactive conversion of aqueous cyanide (CN-aq) to HCN (g) is a particular problem. A vessel (1, 2, 3) and a leach circuit for conducting the solid/liquid process is also disclosed.
Patent CA-2575760-A1 (CA)
Title: Selected betaines and their uses
Inventor: MESSADEK JALLAL
IPC: A61P7/02
Filed: 2004-08-03
Abstract: A physiologically acceptable, sterile and pyrogen-free solution of betaine dissolved in a physiologically acceptable solvent, having a pH adjusted to from 5.0 to 8.0 with a betaine concentration of from 5 to 500mg/ml.
Patent CA-2576601-A1 (CA)
Inventor: VENTURA RIBEIRO DE MATOS ANTON
IPC: A01K69/10
Filed: 2007-02-01
Abstract: The present invention concerns a box-like fish-trap (1) comprising a frame, which is foldable, involved by a net, characterised in that it consists of:   - A metallic upper body (2), which floats;  - A metallic lower body (3);   - Flexible cables (4) to fix the upper body (2) to the lower body (3);   - Flexible side nets which connect the lower body (3) to the upper body (2);   - Frames (6, 7) that hold the nets of the fish entrance openings (5) and which are arranged so as to let the fish come in but make it difficult for it to get out; and - One bottom (16) formed by a frame and net fixed in an articulated manner to one of the tops of the lower body and closed at the opposite top, which will make it possible to collect the captured fish.
Patent CA-2580429-A1 (CA)
Title: Compositions and methods for producing steviol and steviol glycosides
Inventor: BRANDLE JIM
IPC: C12N15/63
Filed: 2007-03-21
Abstract: The present invention relates to nucleotide sequences encoding ent-kaurenoic acid 13--hydroxylase polypeptides and polypeptides having ent-kaurenic acid 13-hydroxylase activity. The invention also relates to methods of producing steviol and steviol glycosides.
Patent CA-2581560-A1 (CA)
Inventor: KIST EDWARD D
IPC: C08F10/00
Filed: 2005-08-16
Abstract: The invention relates to supports comprising inorganic oxide nanoparticles coated with magnesium chloride and a method for making them. The inorganic oxide has a mean particle diameter of less than 5 microns and is used as a seed to crystallize magnesium chloride from solution. The magnesium chloride-coated inorganic oxide is useful for supporting transition metal compounds;  the supported transition metal compounds are used as catalysts for polymerizing olefins.
Patent CA-2582722-A1 (CA)
Title: Intestinal polyp inhibitor
Inventor: WAKABAYASHI KEIJI
IPC: A61K31/662
Filed: 2005-09-30
Abstract: It is intended to provide a drug having effects of preventing the formation of intestinal polyps, which might induce intestinal cancer, preventing the progress thereof and treating the same. Namely, an intestinal polyp inhibitor which contains as the active ingredient a carboxylic acid amide represented by the following general formula, in particular, 4-diethoxyphosphinoylmethyl-N-(4-bromo-2-cyanophenyl)benzamide: wherein R represents a lower alkyl group; and X  represents a halogen atom.